| DANH MỤC BÀI BÁO QUỐC TẾ THÁNG 5/2020 |
| STT |
TÊN BÀI BÁO |
LINK BÀI BÁO |
TÊN BÁO/TẠP CHÍ |
TÁC GIẢ |
NGÀY ĐĂNG |
| 1 |
Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32359227 |
American journal of perinatology |
Buonsenso D1, Costa S#1, Sanguinetti M2, Cattani P2, Posteraro B2, Marchetti S2, Carducci B1, Lanzone A1, Tamburrini E2, Vento G1, Valentini P1. |
2/5/2020 |
| 2 |
A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32359203 |
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine |
Chowdhury MS1, Rathod J1, Gernsheimer J2. |
2/5/2020 |
| 3 |
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32359180 |
Journal of the European Academy of Dermatology and Venereology : JEADV |
Ehsani AH1, Nasimi M1, Bigdelo Z2. |
2/5/2020 |
| 4 |
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32359035 |
Clinical and experimental rheumatology |
Sciascia S1, Aprà F2, Baffa A1, Baldovino S1, Boaro D2, Boero R2, Bonora S2, Calcagno A2, Cecchi I1, Cinnirella G2, Converso M2, Cozzi M1, Crosasso P2, De Iaco F2, Di Perri G2, Eandi M2, Fenoglio R1, Giusti M2, Imperiale D2, Imperiale G2, Livigni S2, Manno E2, Massara C1, Milone V2, Natale G2, Navarra M2, Oddone V1, Osella S2, Piccioni P2, Radin M1, Roccatello D3, Rossi D1. |
1/5/2020 |
| 5 |
Evaluation of COVID-19 RT-qPCR test in multi-sample pools. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32358960 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
Yelin I1, Aharony N1, Shaer Tamar E1, Argoetti A1, Messer E2, Berenbaum D1, Shafran E3, Kuzli A3, Gandali N3, Shkedi O4, Hashimshony T1, Mandel-Gutfreund Y1,5, Halberthal M6,4, Geffen Y7, Szwarcwort-Cohen M3, Kishony R1,5. |
2/5/2020 |
| 6 |
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32358203 |
Science (New York, N.Y.) |
Yin W#1,2, Mao C#2, Luan X#3,4,5, Shen DD#2, Shen Q#2, Su H#1,6, Wang X1, Zhou F1, Zhao W1, Gao M7, Chang S8,9, Xie YC1, Tian G1, Jiang HW10, Tao SC10, Shen J1,6, Jiang Y1,6, Jiang H1,6, Xu Y11,6, Zhang S12,5,3, Zhang Y13,14, Xu HE11,6. |
1/5/2020 |
| 7 |
SARS-CoV-2 productively infects human gut enterocytes |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32358202 |
Science (New York, N.Y.) |
Lamers MM#1, Beumer J#2, van der Vaart J#2, Knoops K3, Puschhof J2, Breugem TI1, Ravelli RBG3, Paul van Schayck J3, Mykytyn AZ1, Duimel HQ3, van Donselaar E3, Riesebosch S1, Kuijpers HJH3, Schippers D1, van de Wetering WJ3, de Graaf M1, Koopmans M1, Cuppen E4,5, Peters PJ3, Haagmans BL#1, Clevers H#6. |
1/5/2020 |
| 8 |
How related is SARS-CoV-2 to other coronaviruses? |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32358120 |
The Veterinary record |
Chen N1, Li X1, Li S1, Xiao Y1, Ye M1, Yan X1, Li X1. |
2/5/2020 |
| 9 |
Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32358057 |
RNA (New York, N.Y.) |
Esbin MN1, Whitney ON1, Chong S1, Maurer A1, Darzacq X1, Tjian R2. |
1/5/2020 |
| 10 |
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32357545 |
Pathogens (Basel, Switzerland) |
Koyama T1, Weeraratne D2, Snowdon JL2, Parida L1. |
26/4/2020 |
| 11 |
Observations about sexual and other routes of SARS-CoV-2 transmission and its prevention. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32369619 |
Clinical and experimental dermatology |
Tatu AL1,2, Nadasdy T1, Nwabudike LC3. |
5/5/2020 |
| 12 |
Thrombocytopenia as an initial manifestation of Covid-19; Case Series and Literature review. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32369609 |
British journal of haematology |
Ahmed MZ1, Khakwani M1, Venkatadasari I1, Horgan C1, Giles H1, Jobanputra S1, Lokare A1, Ewing J1, Shankara P1, Murthy V1. |
5/5/2020 |
| 13 |
Estimation of the probability of reinfection with COVID-19 coronavirus by the SEIRUS model |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32369029 |
JMIR public health and surveillance |
Victor AO1 |
4/5/2020 |
| 14 |
A Recovered Case of COVID-19 Myocarditis and ARDS Treated with Corticosteroids, Tocilizumab, and Experimental AT-001. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32368755 |
JACC. Case reports |
Coyle J1, Igbinomwanhia E2, Sanchez-Nadales A2, Danciu S1, Chu C3, Shah N1. |
3/5/2020 |
| 15 |
CD4+ T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32348763 |
Cell reports |
Wen J1, Wang YT2, Valentine KM2, Dos Santos Alves RP3, Xu Z2, Regla-Nava JA2, Ngono AE2, Young MP2, Ferreira LCS4, Shresta S5. |
28/4/2020 |
| 16 |
The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32374457 |
Journal of medical virology |
Musarrat F1,2, Chouljenko V1,2, Dahal A3, Nabi R1,2, Chouljenko T4, Jois SD3, Kousoulas KG1,2. |
6/5/2020 |
| 17 |
SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32379909 |
Journal of the European Academy of Dermatology and Venereology : JEADV |
Delfino M1, Guida M2, Patrì A1, Spirito L3, Gallo L1, Fabbrocini G1. |
7/5/2020 |
| 18 |
3CL Hydrolase Based Multi Epitope Peptide Vaccine Against Sars-CoV-2 Using Immunoinformatics. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32379348 |
Journal of medical virology |
Jakhar R1, Kaushik S2, Gakhar SK1. |
7/5/2020 |
| 19 |
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32388470 |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology |
Bordi L1, Piralla A2, Lalle E1, Giardina F2, Colavita F1, Tallarita M2, Sberna G1, Novazzi F2, Meschi S1, Castilletti C1, Brisci A3, Minnucci G3, Tettamanzi V3, Baldanti F4, Capobianchi MR1. |
4/5/2020 |
| 20 |
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32387564 |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases |
van Dorp L1, Acman M1, Richard D2, Shaw LP3, Ford CE1, Ormond L1, Owen CJ1, Pang J4, Tan CCS1, Boshier FAT5, Ortiz AT6, Balloux F7. |
5/5/2020 |
| 21 |
|
|
|
|
|
| 22 |
Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32396769 |
Journal of biomolecular structure & dynamics |
Mittal L1, Kumari A1, Srivastava M1, Singh M1, Asthana S1. |
12/5/2020 |
| 23 |
Recent progress on the diagnosis of 2019 Novel Coronavirus. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32395897 |
Transboundary and emerging diseases |
Li C1, Ren L2. |
12/5/2020 |
| 24 |
Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32395713 |
Medicine in drug discovery |
Reiter RJ1, Sharma R1, Ma Q1, Dominquez-Rodriguez A2, Marik PE3, Abreu-Gonzalez P4. |
11/5/2020 |
| 25 |
An Update on Current Therapeutic Drugs Treating COVID-19. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32395418 |
Current pharmacology reports |
Wu R1, Wang L1, Kuo HD1, Shannar A1, Peter R1, Chou PJ1, Li S1, Hudlikar R1, Liu X1,2, Liu Z1,3, Poiani GJ4,5, Amorosa L5, Brunetti L4,6, Kong AN1. |
11/5/2020 |
| 26 |
Vector competence of Aedes aegypti from New Caledonia for the four recent circulating dengue virus serotypes |
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008303 |
Plos Neglected Tropical Diseases |
Olivia O’Connor |
14/5/2020 |
| 27 |
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32408391 |
Journal of thrombosis and haemostasis : JTH |
Menezes-Rodrigues FS1, Padrão Tavares JG1, Pires de Oliveira M2, Guzella de Carvalho R3, Ruggero Errante P1, Omar Taha M4, Fagundes DJ4, Caricati-Neto A1. |
14/5/2020 |
| 28 |
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32407364 |
PLoS pathogens |
Liu P1, Jiang JZ2, Wan XF3,4,5,6,7, Hua Y8, Li L1, Zhou J1, Wang X9, Hou F10, Chen J9, Zou J10, Chen J1. |
14/5/2020 |
| 29 |
SARS-CoV-2 detection by direct rRT-PCR without RNA extraction. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32416598 |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology |
Merindol N1, Pépin G2, Marchand C3, Rheault M4, Peterson C5, Poirier A6, Houle C7, Germain H8, Danylo A9. |
7/5/2020 |
| 30 |
Spillover of SARS-CoV-2 into novel wild hosts in North America: A conceptual model for perpetuation of the pathogen. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32416535 |
The Science of the total environment |
Franklin AB1, Bevins SN2. |
12/5/2020 |
| 31 |
COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32418055 |
Journal of neurovirology |
Sepehrinezhad A1,2, Shahbazi A1,3, Negah SS4,5,6. |
16/5/2020 |
| 32 |
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19 |
https://www.nature.com/articles/s41591-020-0931-3 |
Nature Medicine |
Xueyan Mei, |
19/5/2020 |
| 33 |
A single variant sequencing method for sensitive and quantitative detection of HIV-1 minority variants |
https://www.nature.com/articles/s41598-020-65085-y |
Scientific Reports volume |
Gurjit Sidhu, |
18/5/2020 |
| 34 |
Spontaneous Pneumomediastinum: A Probable Unusual Complication of Coronavirus Disease 2019 (COVID-19) Pneumonia |
http://login.research4life.org/32323507/?from_term=covid-19&from_page=21&from_pos=1 |
Korean Journal of Radiology |
Jing Wang 1 2, Xiaoyun Su 1 2, Tianjing Zhang 3, Chuansheng Zheng 1 |
22/5/2020 |
| 35 |
Development of Multi-Specific Humanized Llama Antibodies Blocking SARS-CoV-2/ACE2 Interaction With High Affinity and Avidity |
http://login.research4life.org/32403995/?from_term=covid-19&from_sort=pubdate&from_pos=5 |
Emerg Microbes Infect |
Jianbo Dong |
25/5/2020 |
| 36 |
Cutaneous Hyperesthesia: A Novel Manifestation of COVID-19 |
http://login.research4life.org/32464157/?from_term=covid-19&from_sort=date&from_page=6&from_pos=2 |
Brain Behav Immun |
Piotr K Krajewski 1, Jacek C Szepietowski 2, Joanna Maj 1 |
25/5/2020 |